Evidence map›Paper›PMID 35058262›Full record

ArticleBMJ open2022

Study protocol of the European Urban Burden of Disease Project: a health impact assessment study.

Mark J Nieuwenhuijsen, Jose Barrera-Gómez, Xavier Basagaña, Marta Cirach, Carolyn Daher, Maria Foraster Pulido, Tamara Iungman, Antonio Gasparrini, Gerard Hoek, Kees de Hoogh and 11 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 6 countries.

Mark J NieuwenhuijsenBarcelona Institute for Global Health, Barcelona, Spain mark.nieuwenhuijsen@isglobal.org.ORCID 0000-0001-9461-7981
Jose Barrera-GómezBarcelona Institute for Global Health, Barcelona, Spain.
Xavier BasagañaBarcelona Institute for Global Health, Barcelona, Spain.
Marta CirachBarcelona Institute for Global Health, Barcelona, Spain.
Carolyn DaherBarcelona Institute for Global Health, Barcelona, Spain.
Maria Foraster PulidoBarcelona Institute for Global Health, Barcelona, Spain.
Tamara IungmanBarcelona Institute for Global Health, Barcelona, Spain.
Antonio GasparriniLondon School of Hygiene & Tropical Medicine, London, UK.
Gerard HoekIRAS, Utrecht University Faculty of Veterinary Medicine, Utrecht, Netherlands.
Kees de HooghSwiss Tropical and Public Health Institute, Basel, Switzerland.
Sasha KhomenkoBarcelona Institute for Global Health, Barcelona, Spain.
Haneen KhreisTexas A&M University System, College Station, Texas, USA.
Audrey de NazelleImperial College London, London, London, UK.
Ana RamosBarcelona Institute for Global Health, Barcelona, Spain.
David Rojas-RuedaColorado State University System, Fort Collins, Colorado, USA.ORCID 0000-0001-5854-2484
Evelise Pereira BarbozaBarcelona Institute for Global Health, Barcelona, Spain.ORCID 0000-0002-2995-7418
Marko TainioSYKE, Helsinki, Finland.
Meelan ThondooBarcelona Institute for Global Health, Barcelona, Spain.
Cathryn TonneBarcelona Institute for Global Health, Barcelona, Spain.
James WoodcockIPH, Cambridge University, Cambridge, UK.
N MuellerBarcelona Institute for Global Health, Barcelona, Spain.
Barcelona Institute for Global Health · ESColorado State University System · USImperial College London · GBLondon School of Hygiene & Tropical Medicine · GBPolish Academy of Sciences · PLSwiss Tropical and Public Health Institute · CHTexas A&M University System · USUniversitat Pompeu Fabra · ESUniversity of Cambridge · GBUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCities have long been known to be society's predominant engine of innovation and wealth creation, yet they are also hotspots of pollution and disease partly due to current urban and transport practices. The aim of the European Urban Burden of Disease project is to evaluate the health burden and its determinants related to current and future potential urban and transport planning practices and related exposures in European cities and make this evidence available for policy and decision making for healthy and sustainable futures. METHODS AND ANALYSIS: Drawing on an established comparative risk assessment methodology (ie, Urban and Transport Planning Health Impact Assessment) tool), in nearly 1000 European cities we will (1) quantify the health impacts of current urban and transport planning related exposures (eg, air pollution, noise, excess heat, lack of green space) (2) and evaluate the relationship between current levels of exposure, health impacts and city characteristics (eg, size, density, design, mobility) (3) rank and compare the cities based on exposure levels and the health impacts, (4) in a number of selected cities assess in-depth the linkages between urban and transport planning, environment, physical activity and health, and model the health impacts of alternative and realistic urban and transport planning scenarios, and, finally, (5) construct a healthy city index and set up an effective knowledge translation hub to generate impact in society and policy. ETHICS AND DISSEMINATION: All data to be used in the project are publicly available data and do not need ethics approval. We will request consent for personal data on opinions and views and create data agreements for those providing information on current and future urban and transport planning scenarios.For dissemination and to generate impact, we will create a knowledge translation hub with information tailored to various stakeholders.

Indexed as

Air PollutionHealth Impact AssessmentCitiesCity PlanningCost of IllnessHumansUrban Healthepidemiologyhealth policypublic health

Identifiers

PMID35058262
PMCPMC8783806
OpenAlexW4205769361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.